Material CAS 1260141-27-2 Vonoprazan Fumarate API Vonoprazan Fumarate Powder Tak 438 Vonoprazan Fumarate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Vonoprazan Fumarate
• Product Name: Vonoprazan Fumarate
• Name: Vonoprazan Fumarate Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No: 1260141-27-2
• Mf: C21h20fn3o6s
• MW: 461.46300
• Storage Temperature: Cool Dry Place
• Certificate: ISO 9001
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

Material CAS 1260141-27-2 Vonoprazan Fumarate API Vonoprazan Fumarate Powder Tak 438 Vonoprazan Fumarate

Product Description

Product Details

Product name	Vonoprazan Fumarate
Cas number	1260141-27-2
Appearance	White powder
MF	C21H20FN3O6S
MW	461.46300

Treatment of duodenal ulcer, gastric ulcer and reflux esophagitis, low-dose aspirin-induced gastric ulcer or recurrent duodenal
ulcer.Helicobacter pylori eradication, adjuvant treatment of the following diseases: gastric ulcer, duodenal ulcer, gastric MALT
lymphoma, idiopathic thrombocytopenic purpura, early gastric cancer, Helicobacter pylori-infected gastritis.

Application&Function

Vonoprazan can be used for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
Vonoprazan fumarate shows strong and sustainable acid secretion inhibitory effects as well as demonstrate efficacy in early termination by inhibiting the binding of potassium ion (K+) to H+, K+-ATPase (proton pump) in the final step of gastric acid secretion in gastric parietal cells.

Specification